Axonics Inc
(STU:0I3)
€
61.5
0 (0%)
Market Cap: 3.19 Bil
Enterprise Value: 2.91 Bil
PE Ratio: 0
PB Ratio: 5.47
GF Score: 86/100 Axonics Inc at Wolfe Research Healthcare Conference Transcript
Nov 14, 2023 / 05:30PM GMT
Release Date Price:
€48.2
(+2.12%)
Michael K. Polark
Wolfe Research, LLC - Director & Senior Analyst
Welcome. Good afternoon. My name is Mike Polark, medical device analyst at Wolfe Research, and pleased to be joined in this session by Axonics, CEO, Raymond Cohen; CFO, Kari Keese; and VP of Investor Relations in the audience, Neil Bhalodkar. Guys, thanks for being here.
Raymond W. Cohen
Axonics, Inc. - CEO & Director
Our pleasure.
Questions & Answers
Michael K. Polark
Wolfe Research, LLC - Director & Senior Analyst
Look, the format is some Q&A, but I'd like to give folks an opportunity to set the stage, introduce Axonics, kind of state of the business, how things are going? Who is Axonics? How about that? What is your mission?
Raymond W. Cohen
Axonics, Inc. - CEO & Director
That's a big picture question. We're focused on treating patients with incontinence, whether you have a problem where you have great urgency and can't get to the bathroom in time, which is called
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot